Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation

Area of Science:

• Neuroscience
• Molecular Biology
• Neurodegenerative Diseases

Background:

• Hyperphosphorylation of the tau protein is a key feature of neurodegenerative tauopathies, including Alzheimer's disease.
• The progressive nature of tau hyperphosphorylation remains a critical unanswered question in the field.

Purpose of the Study:

• To elucidate the mechanisms governing progressive tau hyperphosphorylation.
• To identify key regulatory sites and kinases involved in tau phosphorylation.
• To explore therapeutic strategies targeting tau phosphorylation for tauopathies.

Main Methods:

• Systematic assessment of tau phosphorylation site interdependence.
• CRISPR point mutation and expression of human tau in a mouse model of Alzheimer's disease.
• Combined targeting of identified master phosphorylation sites and the p38α kinase.

Main Results:

• Identified specific tau residues (threonine-50, threonine-69, threonine-181) as 'master sites' controlling phosphorylation propagation.
• Demonstrated that site interdependence governs both physiological and amyloid-associated tau phosphorylation and cognitive deficits in vivo.
• Showed synergistic ablation of hyperphosphorylation upon combined targeting of master sites and p38α kinase.

Conclusions:

• Tau phosphorylation is regulated by a mechanism of site interdependence, linking initial phosphorylation events to widespread modification.
• Master phosphorylation sites and the p38α kinase are critical regulators of tau hyperphosphorylation.
• Targeting these master sites and p38α kinase presents a promising synergistic therapeutic strategy for tauopathies.